Mesoblast likely to raise cash after FDA setbackThe stem cell-focused biotech has been rebuffed again by the US Food and Drug Administration, hitting its shareholder hard, including billionaire Melbourne investor Alex Waislitz.
Source: https://www.theaustralian.com.au/subscribe/news/1/?sourceCode=TAWEB_WRE170_a_GGL&dest=https%3A%2F%2Fwww.theaustralian.com.au%2Fbusiness%2Fcompanies%2Fmesoblast-raises-an-extra-605m-still-has-alex-waislitzs-support-who-concedes-its-been-a-long-journey%2Fnews-story%2Fc8be3e464d46c6016dcca96b261b68ee&memtype=anonymous&mode=premium&v21=dynamic-high-test-score&V21spcbehaviour=appendend
Ann: Change in substantial holding, page-65
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |